Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Citi downgrades IPG Photonics stock rating to Sell on dim outlook

EditorRachael Rajan
Published 02/15/2024, 09:52 AM
Updated 02/15/2024, 09:52 AM
© Reuters.

On Thursday, Citi issued a downgrade for IPG Photonics (NASDAQ:IPGP) Corporation (NASDAQ:IPGP), shifting its rating from Neutral to Sell and reducing the price target significantly from $111.00 to $74.00. The decision follows the company's fourth-quarter 2023 results and its first-quarter 2024 guidance, which indicated a challenging outlook ahead.

The downgrade was influenced by a revision of the firm's revenue and gross profit margin (GPM) forecasts for both 2024 and 2025. Citi now anticipates a more pronounced earnings decline for IPG Photonics in 2024, with a roughly 22% and 16% reduction in earnings forecasts for 2024 and 2025, respectively. This reassessment stems from weaker-than-expected guidance and broader macroeconomic concerns.

Citi also adjusted its valuation approach for IPG Photonics, applying a lower price-to-earnings (P/E) ratio of 20 times, down from the previous 25 times. This change reflects the anticipated continuous earnings decline through 2024.

"Comparing with our previous expectation that IPGP could see earnings recovery in 2024, we now expect the turnaround to postpone to 2025 given the global macro headwinds in 2024...and weaker PMIs of major economies," said Citi.

In contrast to IPG Photonics, Citi expressed a preference for Raycus (300747.SZ) within the global laser source segment. The preference is based on Raycus's stronger earnings growth potential from a lower starting point.

InvestingPro Insights

As IPG Photonics Corporation (NASDAQ:IPGP) faces a downgrade from Citi, with a significant price target cut, it's crucial to consider various financial metrics and market signals. InvestingPro data indicates that IPGP has a market capitalization of approximately $4.12 billion, and its adjusted price-to-earnings (P/E) ratio for the last twelve months as of Q4 2023 stands at 18.53, suggesting a valuation that is more conservative than Citi's applied P/E ratio of 20 times.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Despite the challenging outlook, IPGP's financial health appears robust with InvestingPro Tips highlighting that the company holds more cash than debt on its balance sheet and has a high shareholder yield. These factors may provide some resilience in the face of macroeconomic headwinds. Moreover, the stock's recent performance, with a one-week total price return of -13.02%, might reflect investor concerns but also indicates that the stock is in oversold territory according to the Relative Strength Index (RSI), a potential signal for contrarian investors.

For readers interested in a deeper dive into IPGP's financials and future prospects, InvestingPro offers additional insights. There are 12 InvestingPro Tips available for IPGP, which can be accessed at https://www.investing.com/pro/IPGP. These tips include an analysis of sales trends, profitability expectations, and liquidity positions, which are crucial for making informed investment decisions.

For those considering an InvestingPro subscription, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, unlocking further insights into IPGP's market performance and financial health.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.